跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,237 条关于
“Parataxis Holdings LLC”
全部
4,237
临床试验
612
药物
516
机构
1,828
资讯
1,281
去年
Bridge Biotherapeutics Pivots to Bitcoin Treasury Strategy Following Clinical Trial Failures
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
Ignite Proteomics' RPPA Assay Drives Complete Response in HER2-Negative Breast Cancer
去年
Rafael Holdings Completes $25 Million Rights Offering to Fund Trappsol Cyclo Phase 3 Trial for Rare Disease
去年
Shuttle Pharmaceuticals Announces $4.5 Million Public Offering to Advance Ropidoxuridine Clinical Trials
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
第 1 页,共 129 页
上一页
下一页